Security | RGEN / Repligen Corporation |
Insider | Olivier Loeillot |
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Olivier Loeillot in RGEN / Repligen Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
---|---|---|---|---|---|---|---|
There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Olivier Loeillot in RGEN / Repligen Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
---|---|---|---|---|---|---|---|
There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-04 | 2025-09-03 | 4 | Loeillot Olivier | RGEN | Common Stock | D | 116.1800 | -2,506 | -291 | 44,187 | ||||
2025-03-04 | 2025-03-03 | 4 | Loeillot Olivier | RGEN | Common Stock | D | 14,480 | 46,693 | ||||||
2025-02-28 | 2025-02-27 | 4 | Loeillot Olivier | RGEN | Common Stock | D | 156.5400 | -343 | -54 | 32,213 | ||||
2024-11-21 | 2024-11-20 | 4 | Loeillot Olivier | RGEN | Common Stock | D | 123.4100 | -861 | -106 | 32,556 | ||||
2024-09-04 | 2024-09-03 | 4 | Loeillot Olivier | RGEN | Common Stock | D | 17,631 | 33,417 | ||||||
2024-02-29 | 2024-02-27 | 4 | Loeillot Olivier | RGEN | Common Stock | D | 2,880 | 15,786 | ||||||
2023-10-03 | 2023-10-02 | 4 | Loeillot Olivier | RGEN | Common Stock | D | 12,906 | 12,906 |